I attended and my opinion was nothing new other than reiterating the timeline for AMP945 application for idiopathic pulmonary fibrosis + pancreatic cancer regarding trials and data collection etc. Majority was spent voting on agenda items. There was no set time provided at the end for asking questions which i found odd. Not sure if this is normal now we are using zoom. Dr Lambert read off a a script most of the time. Market seems to have reacted well though.
I attended and my opinion was nothing new other than reiterating...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
-0.003(4.13%) |
Mkt cap ! $15.75M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 6.1¢ | 5.8¢ | $30.32K | 507.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 57229 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.1¢ |
Change
-0.003 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 6.0¢ | 6.1¢ | 5.9¢ | 360164 | ||
| Last updated 14.41pm 17/05/2024 ? | |||||
| ATX (ASX) Chart |